JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 24, 2003; DOI: 10.1124/jpet.102.048025

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.048025v1
305/2/507    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammoun, S.
Right arrow Articles by Kukkonen, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammoun, S.
Right arrow Articles by Kukkonen, J. P.

Vol. 305, Issue 2, 507-514, May 2003

Distinct Recognition of OX1 and OX2 Receptors by Orexin Peptides

Sylwia Ammoun, Tomas Holmqvist, Ramin Shariatmadari, Hendrica B. Oonk, Michel Detheux, Marc Parmentier, Karl E. O. Åkerman and Jyrki P. Kukkonen

Department of Neuroscience, Physiology, and Laboratory of Cell Physiology, Uppsala University, Uppsala, Sweden (S.A., T.H., R.S., K.E.O.Å., J.P.K.); Department of Molecular Recognition, ID-Lelystand Institute for Animal Science and Health, Lelystad, the Netherlands (H.B.O.); Euroscreen S.A., Bruxelles, Belgium (M.D.); The Institute of Interdisciplinary Research, Université Libre de Bruxelles, Bruxelles, Belgium (M.P.); and the A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland (K.E.O.Å.)

In this study, we have compared the abilities of orexin-A and orexin-B and variants of orexin-A to activate different Ca2+ responses (influx and release) in human OX1 and OX2 receptor- expressing Chinese hamster ovary cells. Responses mediated by activation of both receptor subtypes with either orexin-A or -B were primarily dependent on extracellular Ca2+, suggesting similar activation of Ca2+ influx as we have previously shown for orexin-A and OX1 receptors. Amino acid-wise truncation of orexin-A reduced its ability to activate OX1 and OX2 receptors, but the response mediated by the OX2 receptor was more resistant to truncation than the response mediated by the OX1 receptor. We also performed a sequential replacement of amino acids 14 to 26 with alanine in the truncated orexin-A variant orexin-A14-33. Replacement of the same amino acids produced a fall in the potency for each receptor subtype, but the reduction was less prominent for the OX2 receptor. The most marked reduction was produced by the replacement of Leu20, Asp25, and His26 with alanine. Interestingly, extracellular Ca2+ dependence of responses to some of the mutated peptides was different from those of orexin-A and -B. The mutagenesis also suggests that although the determinants required from orexin-A for binding to and activation of the receptor are highly conserved between the orexin receptor subtypes, the OX2 receptor requires fewer determinants. This might in part explain why orexin-B has the affinity and potency equal to orexin-A for this subtype, although it has 10- to 100-fold lower affinity and potency for the OX1 receptor.

0022-3565/03/3052-0507$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 EndocrinologyHome page
M. Ramanjaneya, A. C. Conner, J. Chen, P. R. Stanfield, and H. S. Randeva
Orexins Stimulate Steroidogenic Acute Regulatory Protein Expression through Multiple Signaling Pathways in Human Adrenal H295R Cells
Endocrinology, August 1, 2008; 149(8): 4106 - 4115.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Silveyra, V. Lux-Lantos, and C. Libertun
Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E977 - E985.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Silveyra, P. N. Catalano, V. Lux-Lantos, and C. Libertun
Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E820 - E828.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Nasman, G. Bart, K. Larsson, L. Louhivuori, H. Peltonen, and K. E. O. Akerman
The Orexin OX1 Receptor Regulates Ca2+ Entry via Diacylglycerol-Activated Channels in Differentiated Neuroblastoma Cells.
J. Neurosci., October 18, 2006; 26(42): 10658 - 10666.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer
Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling
Mol. Endocrinol., January 1, 2006; 20(1): 80 - 99.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Spinazzi, M. Rucinski, G. Neri, L. K. Malendowicz, and G. G. Nussdorfer
Preproorexin and Orexin Receptors Are Expressed in Cortisol-Secreting Adrenocortical Adenomas, and Orexins Stimulate in Vitro Cortisol Secretion and Growth of Tumor Cells
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3544 - 3549.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Holmqvist, L. Johansson, M. Ostman, S. Ammoun, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Couple to Adenylyl Cyclase Regulation via Multiple Mechanisms
J. Biol. Chem., February 25, 2005; 280(8): 6570 - 6579.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J.-K. Cheng, R. C.-C. Chou, L.-L. Hwang, and L.-C. Chiou
Antiallodynic Effects of Intrathecal Orexins in a Rat Model of Postoperative Pain
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1065 - 1071.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.